CIK 0000842023 · Large accelerated filer
BIO-TECHNE Corp
Sign in to watch- Ticker
- TECH
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411427402
- Phone
- 612-379-8854
- Business address
- 614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
- Former names
- TECHNE CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-08-05 | Hippel James Chief Financial Officer | Grant or award · Stock Options (Right to Buy) | +14,360 | 14,360 | ||
| 2020-08-05 | Hippel James Chief Financial Officer | Grant or award · Stock Options (Right to Buy) | +19,147 | 19,147 | ||
| 2020-08-05 | Hippel James Chief Financial Officer | Grant or award · Stock Options (Right to Buy) | +8,325 | 8,325 | ||
| 2020-08-05 | Hippel James Chief Financial Officer | Grant or award · Stock Options (Right to Buy) | +8,325 | 8,325 | ||
| 2020-08-05 | Furlow Brenda S. SVP - General Counsel | Grant or award · Restricted Stock Units | +1,679 | 1,679 | ||
| 2020-08-05 | Furlow Brenda S. SVP - General Counsel | Grant or award · Stock Options (Right to Buy) | +7,492 | 7,492 | ||
| 2020-08-05 | Furlow Brenda S. SVP - General Counsel | Grant or award · Stock Options (Right to Buy) | +9,990 | 9,990 | ||
| 2020-08-05 | Furlow Brenda S. SVP - General Counsel | Grant or award · Stock Options (Right to Buy) | +8,325 | 8,325 | ||
| 2020-08-05 | Furlow Brenda S. SVP - General Counsel | Grant or award · Stock Options (Right to Buy) | +8,325 | 8,325 | ||
| 2020-08-05 | Eansor Norman David President-Protein Sciences | Grant or award · Restricted Stock Units | +2,575 | 2,575 | ||
| 2020-08-05 | Eansor Norman David President-Protein Sciences | Grant or award · Stock Options (Right to Buy) | +11,488 | 11,488 | ||
| 2020-08-05 | Eansor Norman David President-Protein Sciences | Grant or award · Stock Options (Right to Buy) | +15,318 | 15,318 | ||
| 2020-08-05 | Eansor Norman David President-Protein Sciences | Grant or award · Stock Options (Right to Buy) | +24,975 | 24,975 | ||
| 2020-08-05 | Eansor Norman David President-Protein Sciences | Grant or award · Stock Options (Right to Buy) | +24,975 | 24,975 | ||
| 2020-08-03 | Bushman Julie L Director | Grant or award | +89 | 89 | ||
| 2020-08-03 | Bushman Julie L Director | Grant or award · Stock Option (Right to Buy) | +361 | 361 | ||
| 2020-07-09 | Furlow Brenda S. SVP - General Counsel | Option exercise | +9,079 | $108.49 | $985K | 13,390 |
| 2020-07-09 | Furlow Brenda S. SVP - General Counsel | Sale | −440 | $270.97 | $119K | 12,950 |
| 2020-07-09 | Furlow Brenda S. SVP - General Counsel | Sale | −505 | $272.48 | $138K | 12,445 |
| 2020-07-09 | Furlow Brenda S. SVP - General Counsel | Sale | −2,042 | $273.33 | $558K | 10,403 |
Page 42 of 53 · 1,043 trades